/ blend

Retatrutide / Cagrilintide Blend

Triple-receptor agonist combined with amylin analog. Cutting-edge metabolic research blend.

/ components

In this blend

Retatrutide (GLP-3)

Research: ★★★★

Next-generation triple receptor agonist. Phase 3 clinical research underway.

View full research →

Cagrilintide

Research: ★★★

Amylin analog. Often researched alongside GLP-1 compounds for synergistic effects.

View full research →

/ standard ratios

Common formulation

Typically 5mg Reta + 5mg Cagri per 10mg vial

/ buying separately vs blend

Cost comparison

Retatrutide (GLP-3)

5mg at Throne

$69.51

Cagrilintide

5mg at Biocase Innovations

$80.42

Total if bought separately

Compare this to blend pricing at any supplier

$149.93

Note: Blend pricing varies by supplier and isn't always cheaper than buying separately. This breakdown shows what you'd pay buying the components individually at the cheapest supplier for each — useful as a price comparison baseline.